Stada's $5.9 Billion Sale Fails as Investors Spurn Takeover

(Bloomberg) -- Stada Arzneimittel AG’s months-long sale process unraveled as a small group of the German drugmaker’s investors held out for a better deal than the 5.3 billion-euro ($5.9 billion) of...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.